Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Abstract
Naturally arising CD25(+)CD4(+) regulatory T cells actively maintain immunological self-tolerance. Deficiency in or dysfunction of these cells can be a cause of autoimmune disease. A reduction in their number or function can also elicit tumor immunity, whereas their antigen-specific population expansion can establish transplantation tolerance. They are therefore a good target for designing ways to induce or abrogate immunological tolerance to self and non-self antigens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Growing evidence has shown that Treg cells are recruited into the TME and behave as powerful immunosuppressors.61, 62”
From Reactive Oxygen Species in Cancer: Current Findings and Future Directions (2021) · cites this paper as [62]
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Self-citationFoxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745 · cited 1×
“In addition, they specifically express Foxp3 , which encodes a transcription factor, as a key control gene in their development and functio”
BackgroundPark, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Self-citationA CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Sakaguchi, S. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,306
Self-citationThe Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032 · cited 1×
“The fact that many tumor-associated antigens recognized by autologous T cells in cancer patients are antigenically normal self constituents indicates that natural CD25 + CD4 + T reg cells engaged in the maintenance of self-tolerance may concomitantly impede immunosurveillance against autologous tumor cell”
BackgroundTivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Research works printed but not linked: 1
- Setoguchi, R., Hori, S., Takahashi, T. & Sakaguchi, S. A crucial role of IL-2 in the homeostatic maintenance of CD25+CD4+ regulatory T cells: induction of autoimmune disease by neutralization of IL-2. J. Exp. Med. (in the press).
Cited by
Items 301–400 of 1,010
Shalev, I., Liu, H., Koscik, C., Bartczak, A., Javadi, M., Wong, K. M., Maknojia, A., He, W., Liu, M. F., Diao, J., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.249 · Cited by 160
“Alteration in CD4 CD25 Treg cell numbers or activity has been shown to be associated with autoimmune diseases (31).”
BackgroundThe regulation of Foxp3 expression in regulatory CD4+CD25+T cells: Multiple pathways on the road
Zhang, L., & Zhao, Y. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21001 · Cited by 158
“Recently, great progress has been made on the identification and characterization of regulatory T cells (Treg cells) which play important roles in immune tolerance to self and transplant antigens (Jiang and Lechler, 2003; Sakaguchi, 2004, 2005; Waldmann et al., 2004; Schwartz, 2005).”
BackgroundBaranwal, M., Putzki, N., Limmroth, V., Remus, R., Lindemann, M., Knop, D., Mueller, N., Hardt, C., Kreuzfelder, E., & Grosse‐Wilde, H. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.08.003 · Cited by 160
“T reg cells are characterized by the expression of CD4 + and CD25 + and more specifically they express the message for the transcription factor forkhead box P3 (FOXP3) as a key control gene for development and function (Sakaguchi, 2005).”
Targeting IL-2: an unexpected effect in treating immunological diseases
Ye, C., Brand, D., & Zheng, S. G. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-017-0002-5 · Cited by 155
Li, J.-Y., Duan, X.-F., Wang, L.-P., Xu, Y.-J., Huang, L., Zhang, T.-F., Liu, J.-Y., Li, F., Zhang, Z., Yue, D.-L., et al. (2014) · Journal of Immunology Research · doi:10.1155/2014/286170 · Cited by 157
Caturegli, P., Kimura, H. J., Rocchi, R., & Rose, N. R. (2006) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3280113d1a · Cited by 176
New perspectives of Lactobacillus plantarum as a probiotic: The gut-heart-brain axis
Liu, Y.-W., Liong, M., & Tsai, Y.-C. (2018) · The Journal of Microbiology · doi:10.1007/s12275-018-8079-2 · Cited by 174
Colorectal cancer immunotherapy-Recent progress and future directions
Zhao, W., Jin, L., Chen, P., Li, D., Gao, W., & Dong, G. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215816 · Cited by 164
Disturbed Th1, Th2, Th17 and Treg balance in patients with systemic lupus erythematosus
Dolff, S., Bijl, M., Huitema, M. G., Limburg, P. C., Kallenberg, C. G. M., & Abdulahad, W. H. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.08.005 · Cited by 156
“At present, human regulatory T-cells can be characterized by a CD4+CD25highFoxP3+ phenotype [2].”
BackgroundDarrasse-Jèze, G., Bergot, A.-S., Durgeau, A., Billiard, F., Salomon, B. L., Cohen, J. L., Bellier, B., Podsypanina, K., & Klatzmann, D. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36628 · Cited by 138
“The main function of Tregs is thought to be the maintenance of self tolerance, and likewise the control of autoimmune diseases (15).”
BackgroundImmunological adaptations in pregnancy that modulate rheumatoid arthritis disease activity
Förger, F., & Villiger, P. M. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0351-2 · Cited by 168
Natural Regulatory T Cells and Persistent Viral Infection
Li, S., Gowans, E. J., Chougnet, C., Plebanski, M., & Dittmer, U. (2008) · Journal of Virology · doi:10.1128/jvi.01768-07 · Cited by 149
Elpek, K. G., Yolcu, E. S., Franke, D. D. H., Lacelle, C., Schabowsky, R.-H., & Shirwan, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7295 · Cited by 144
“Discussion Naturally occurring CD4 CD25 FoxP3 Treg cells have recently emerged as an important therapeutic target for the prevention or treatment of various immune-based disorders (4).”
BackgroundAppay, V., Jandus, C., Voelter, V., Reynard, S., Coupland, S. E., Rimoldi, D., Lienard, D., Guillaume, P., Krieg, A. M., Cerottini, J.-C., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1670 · Cited by 149
“However, the coexpression of FoxP3 and CD25 on CD4 T cells has been defined as the most appropriate marker of regulatory T cells currently available (40).”
BackgroundCellular senescence impact on immune cell fate and function
Vicente, R., Mausset-Bonnefont, A.-L., Jorgensen, C., Louis-Plence, P., & Brondello, J.-M. (2016) · Aging Cell · doi:10.1111/acel.12455 · Cited by 151
“The most studied Treg cells are the CD4+CD25hiFoxP3+ that are required for self-tolerance and a proper immune response to pathogens (Sakaguchi, 2005).”
BackgroundExpansion of Antigen-Specific Regulatory T Cells with the Topical Vitamin D Analog Calcipotriol
Ghoreishi, M., Bach, P., Obst, J., Komba, M., Fleet, J. C., & Dutz, J. P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804064 · Cited by 148
“Polyclonal Treg prevent autoimmunity and control host immune responses (20).”
BackgroundKurooka, M., & Kaneda, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1615 · Cited by 143
Autoimmune Dysregulation and Purine Metabolism in Adenosine Deaminase Deficiency
Sauer, A. V., Brigida, I., Carriglio, N., & Aiuti, A. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00265 · Cited by 148
Couper, K. N., Blount, D. G., de Souza, J. B., Suffia, I., Belkaid, Y., & Riley, E. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4136 · Cited by 152
“tant for their generation in the periphery (3, 25, 26).”
BackgroundPattern-Recognition Receptors and Gastric Cancer
Castaño‐Rodríguez, N., Kaakoush, N. O., & Mitchell, H. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00336 · Cited by 167
“FOXP3+ Treg cells, which suppress the immune response of antigen-specific T cells, have been demonstrated to play a key role in immunologic tolerance (198).”
BackgroundVaccination against the Forkhead Family Transcription Factor Foxp3 Enhances Tumor Immunity
Nair, S. K., Boczkowski, D., Faßnacht, M., Pisetsky, D. S., & Gilboa, E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2903 · Cited by 159
LaRosa, D. F., & Orange, J. S. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.06.016 · Cited by 216
Indoleamine 2,3 dioxygenase and regulation of T cell immunity
Mellor, A. L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.232 · Cited by 171
Zhu, J., Davidson, T. S., Wei, G., Jankovic, D., Cui, K., Schones, D. E., Guo, L., Zhao, K., Shevach, E. M., & Paul, W. E. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081666 · Cited by 145
T cell-intrinsic role of IL-6 signaling in primary and memory responses
Nish, S. A., Schenten, D., Wunderlich, F. T., Pope, S. D., Gao, Y., Hoshi, N., Yu, S., Yan, X., Lee, H. K., Pasman, L., et al. (2014) · eLife · doi:10.7554/elife.01949 · Cited by 146
“Accordingly, the absence of Foxp3, the lineagedefining transcription factor that is critical for the generation and function of Tregs results in the development of a fatal autoimmune disease (Fontenot and Rudensky, 2005; Sakaguchi, 2005).”
BackgroundThe balance between cytotoxic NK cells and regulatory NK cells in human pregnancy
Saito, S., Nakashima, A., Subaru, M.-H., & Shiozaki, A. (2007) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2007.04.007 · Cited by 147
Legrand, F. A., Nixon, D. F., Loo, C. P., Ono, É., Chapman, J. M., Miyamoto, M., Diaz, R. S., dos Santos, A. M. N., Succi, R. C. M., Abadi, J., et al. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000102 · Cited by 147
“The current phenotypic definition of Treg cells is based primarily on the expression of CD4 and CD25 as well as the selective expression of the transcription factor Foxp3 [39–41].”
BackgroundThe roles for cytokines in the generation and maintenance of regulatory T cells
Wan, Y. Y., & Flavell, R. A. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00407.x · Cited by 165
Apolipoprotein A-I Modulates Regulatory T Cells in Autoimmune LDLr−/−, ApoA-I−/− Mice
Wilhelm, A. J., Zabalawi, M., Owen, J. S., Shah, D., Grayson, J. M., Major, A. S., Bhat, S., Gibbs, D. P., Thomas, M. J., & Sorci-Thomas, M. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.134130 · Cited by 142
T-Cell Responses to Survivin in Cancer Patients Undergoing Radiation Therapy
Schaue, D., Comin-Anduix, B., Ribas, A., Zhang, L., Goodglick, L., Sayre, J. W., Debucquoy, A., Haustermans, K., & McBride, W. H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4462 · Cited by 143
Mikoś, H., Mikoś, M., Obara-Moszyńska, M., & Niedziela, M. (2014) · Endokrynologia Polska · doi:10.5603/ep.2014.0021 · Cited by 168
“found that the percentage of regulatory T cells within the thyroid lymphocyte cells was lower in patients with autoimmune thyroid disease [19, 20].”
BackgroundSoler, D., Chapman, T. R., Poisson, L. R., Wang, L., Cote-Sierra, J., Ryan, M., McDonald, A., Badola, S., Fedyk, E., Coyle, A. J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6940 · Cited by 140
“face marker for naturally occurring TREG cells, although CD25 is also up-regulated on activated T cells (5).”
BackgroundPrimary immune deficiencies with aberrant IgE production
Özcan, E., Notarangelo, L. D., & Geha, R. S. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.10.023 · Cited by 156
A Major Role for Bim in Regulatory T Cell Homeostasis
Chougnet, C. A., Tripathi, P., Lages, C. S., Raynor, J., Sholl, A., Fink, P., Plas, D. R., & Hildeman, D. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001505 · Cited by 136
“Regulatory T cells (Treg), a subset of CD4 T cells, are critical for maintaining self-tolerance (7).”
Natural Regulatory T Cells Control Coronary Arteriolar Endothelial Dysfunction in Hypertensive Mice
Matrougui, K., Elmageed, Z. E. A., Kassan, M., Choi, S. K., Nair, D., González-Villalobos, R. A., Chentoufi, A. A., Kadowitz, P. J., Belmadani, S., & Partyka, M. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.034 · Cited by 143
Owen, R. E., Heitman, J. W., Hirschkorn, D. F., Lanteri, M. C., Biswas, H. H., Martin, J. N., Krone, M., Deeks, S. G., & Norris, P. J. (2010) · AIDS · doi:10.1097/qad.0b013e3283377a1e · Cited by 144
“Regulatory T (Treg) cells are a unique population of CD4+ T cells that have the ability to suppress the activation and proliferation of T cells [13–16].”
BackgroundOral, H. B., Kotenko, S. V., Yılmaz, M., Mani, O., Zumkehr, J., Blaser, K., Akdis, C. A., & Akdis, M. (2006) · European Journal of Immunology · doi:10.1002/eji.200425523 · Cited by 143
Zhao, W., Beers, D. R., Liao, B., Henkel, J. S., & Appel, S. H. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.07.008 · Cited by 137
Mao, C., Wang, S., Xiao, Y., Xu, J., Jiang, Q., Jin, M., Jiang, X., Guo, H., Ning, G., & Zhang, Y. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0904135 · Cited by 141
“Natural CD4CD25 Treg cells, which are the major component of Treg cells, develop in the thymus and represent a subpopulation of ∼10% of the peripheral CD4 T cells (6).”
BackgroundKong, N., Lan, Q., Chen, M., Wang, J., Shi, W., Horwitz, D. A., Quesniaux, V. F. J., Ryffel, B., Liu, Z., Brand, D. D., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34513 · Cited by 142
Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4+CD25+FOXP3+ Regulatory T-Cells
Monti, P., Scirpoli, M., Maffi, P., Piemonti, L., Secchi, A., Bonifacio, E. E., Roncarolo, M., & Battaglia, M. (2008) · Diabetes · doi:10.2337/db08-0138 · Cited by 152
In vivo–activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease
Zhao, D., Zhang, C., Yi, T., Lin, C.-L. V., Todorov, I., KANDEEL, F. R., Forman, S. J., & Zeng, D. (2008) · Blood · doi:10.1182/blood-2008-02-140277 · Cited by 151
Kaufmann, S. H. E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00684 · Cited by 170
“The more refined concept of the better defined subsets of regulatory T cells, however, provided compelling evidence for specific T lymphocytes which not only control immune responses after elimination of invading pathogens, but also prevent autoimmunity and maintain homeostasis (77).”
BackgroundCCR4-dependent regulatory T cell function in inflammatory bowel disease
Yuan, Q., Bromley, S. K., Means, T. K., Jones, K. J., Hayashi, F., Bhan, A. K., & Luster, A. D. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062076 · Cited by 135
“Naturally occurring T reg cells arise spontaneously in vivo, express a unique transcription factor, Foxp3, and control responses to tissue-specifi c autoantigens that are presented to the immune system via mucosal surfaces (3).”
BackgroundGrabenbauer, G. G., Lahmer, G., Distel, L., & Niedobitek, G. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2434 · Cited by 139
Effect of exercise training intensity on murine T‐regulatory cells and vaccination response
Wang, J., Song, H., Tang, X., Yang, Y., Vieira, V. J., Niu, Y., & Ma, Y. (2012) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/j.1600-0838.2010.01288.x · Cited by 136
“CD4(1)CD25(1) Treg cells, a CD4(1) T cell subtype, specifically express Foxp3, a master specific and functional marker of Treg cells (Sakaguchi, 2005).”
BackgroundDendritic Cells Support Homeostatic Expansion of Foxp3+ Regulatory T Cells in Foxp3.LuciDTR Mice
Suffner, J., Hochweller, K., Kühnle, M.-C., Li, X., Kroczek, R. A., Garbi, N., & Hämmerling, G. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902420 · Cited by 131
“R egulatory T cells (Tregs), a subset of CD4 T cells characterized by the expression of CD25 and the nuclear transcription factor Foxp3, have been shown to play a crucial role in maintaining self-tolerance and limiting immune responses to pathogens (1).”
BackgroundHepatitis E virus infection during pregnancy
Wu, C., Wu, X., & Xia, J. (2020) · Virology Journal · doi:10.1186/s12985-020-01343-9 · Cited by 141
Liu, R., Cava, A. L., Bai, X., Jee, Y., Price, M. A., Campagnolo, D. I., Christadoss, P., Vollmer, T. L., Kaer, L. V., & Shi, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.7898 · Cited by 141
“IL-2 is a critical factor in determining the activation and maintenance of CD4 CD25 Treg cells (10, 16).”
BackgroundMethodTuberculosis vaccine development: goals, immunological design, and evaluation
Hoft, D. F. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61036-3 · Cited by 162
Cutaneous Manifestations of Systemic Lupus Erythematosus
Uva, L., Miguel, D., Pinheiro, C., Freitas, J. P., Gomes, M. M., & Filipe, P. (2012) · Autoimmune Diseases · doi:10.1155/2012/834291 · Cited by 144
“Naturally occurring CD4+CD25+ regulatory T cells (Treg) have emerged as another important factor in self-tolerance and mechanisms in autoimmune diseases [26].”
BackgroundVenken, K., Thewissen, M. M., Hellings, N., Somers, V. A., Hensen, K., Rummens, J., & Stinissen, P. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.01.025 · Cited by 144
Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis
Thonhoff, J. R., Simpson, E. P., & Appel, S. H. (2018) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000599 · Cited by 135
Deoxynivalenol, gut microbiota and immunotoxicity: A potential approach?
Liao, Y., Peng, Z., Chen, L., Nussler, A. K., Liu, L., & Yang, W. Q. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.01.013 · Cited by 145
Role of the NLRP3 Inflammasome in Preeclampsia
Shirasuna, K., Karasawa, T., & Takahashi, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00080 · Cited by 157
“In addition, seminal fluid induces and accumulates paternal-specific Tregs that are involved in the preimplantation uterus, and insufficient expansion of Tregs against paternal antigens may trigger spontaneous abortion (25).”
BackgroundInfluentialResolving the identity myth: Key markers of functional CD4+FoxP3+ regulatory T cells
Chen, X., & Oppenheim, J. J. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.05.018 · Cited by 126
Guo, Z. S., Hong, J. A., Irvine, K. R., Chen, G. A., Spiess, P. J., Liu, Y., Zeng, G., Wunderlich, J. R., Nguyen, D. M., Restifo, N. P., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3020 · Cited by 137
“First, if a TAA is constitutively expressed in tumor tissues, anergic/suppressive CD4CD25 T cells may be generated in the periphery as a consequence of repeated antigenic encounter, thus anergy or tolerance to the antigen (51) may also result in the tumor variants generating ‘‘tumor escape’’ phenotype (52).”
BackgroundMechanisms of malignant glioma immune resistance and sources of immunosuppression.
Gomez, G. G., & Kruse, C. A. (2006) · PubMed · Cited by 149
Molling, J. W., de Gruijl, T. D., Glim, J. E., Moreno, M., Rozendaal, L., Meijer, C. J. L. M., van den Eertwegh, A. J. M., Scheper, R. J., von Blomberg, M. E., & Bontkes, H. J. (2007) · International Journal of Cancer · doi:10.1002/ijc.22894 · Cited by 138
The Tolerogenic Function of Regulatory T Cells in Pregnancy and Cancer
Jørgensen, N., Persson, G., & Hviid, T. V. F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00911 · Cited by 151
The phenotypic characterization of naturally occurring regulatory CD4+CD25+ T cells.
Yi, H., Yu, Z., Jiang, L., Zheng, J., & Zhao, Y. L. (2006) · PubMed · Cited by 162
Zhang, Y., Luo, F., Cai, Y., Liu, N., Wang, L., Xu, D., & Chu, Y. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002320 · Cited by 145
Koyama, K., Kagamu, H., Miura, S., Hiura, T., Miyabayashi, T., Itoh, R., Kuriyama, H., Tanaka, H., Tanaka, J., Yoshizawa, H., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1156 · Cited by 145
Cellular and molecular mechanisms in cancer immune escape: a comprehensive review
Bhatia, A., & Kumar, Y. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.865519 · Cited by 131
VEGFR2 is selectively expressed by FOXP3high CD4+ Treg
Suzuki, H., Onishi, H., Wada, J., Yamasaki, A., Tanaka, H., Nakano, K., Morisaki, T., & Katano, M. (2010) · European Journal of Immunology · doi:10.1002/eji.200939887 · Cited by 124
Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice
Filippi, C. M., Estes, E. A., Oldham, J. E., & von Herrath, M. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38503 · Cited by 131
Herbin, O., Ait-Oufella, H., Yu, W., Fredrikson, G. N., Aubier, B., Perez, N., Barateau, V., Nilsson, J., Tedgui, A., & Mallat, Z. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.242800 · Cited by 132
Regulatory T Cell Properties of Chicken CD4+CD25+ Cells
Shanmugasundaram, R., & Selvaraj, R. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002040 · Cited by 146
“Approximately 5% of mature CD4CD8(2) thymocytes express CD25 (29).”
BackgroundStasiolek, M., Bayas, A., Kruse, N., Wieczarkowiecz, A., Toyka, K. V., Gold, R., & Selmaj, K. (2006) · Brain · doi:10.1093/brain/awl043 · Cited by 128
“It was shown that pDCs exposed to CpG ODN stimulated the development of CD4 + CD25 + regulatory T cells from allogeneic naı¨ve CD4 + T cells (Mossman et al., 2004; Sakaguchi, 2005).”
BackgroundRegulatory T cells in human disease and their potential for therapeutic manipulation
Taams, L. S., Palmer, D. B., Akbar, A. N., Robinson, D. S., Brown, Z., & Hawrylowicz, C. M. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02348.x · Cited by 136
Martin, F., Ladoire, S., Mignot, G., Apétoh, L., & Ghiringhelli, F. (2010) · Oncogene · doi:10.1038/onc.2010.174 · Cited by 156
“The nuclear expression of FOXP3 is now considered as the most specific marker for these cells (Sakaguchi, 2005).”
BackgroundLi, B., Samanta, A., Song, X., Iacono, K. T., Brennan, P., Chatila, T. A., Roncador, G., Banham, A. H., Riley, J. L., Wang, Q., et al. (2007) · International Immunology · doi:10.1093/intimm/dxm043 · Cited by 134
Penna, G., Amuchastegui, S., Cossetti, C., Aquilano, F., Mariani, R., Sanvito, F., Doglioni, C., & Adorini, L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8504 · Cited by 133
“These mechanisms of action could explain some of the immunoregulatory properties of VDR agonists in the treatment of EAP, considering that day 3 thymectomy, leading to depletion of the CD4 CD25 regulatory T cell pool (61), can induce autoimmune prostatitis (62).”
BackgroundTodryk, S. M., Bejon, P., Mwangi, T., Plebanski, M., Urban, B. C., Marsh, K., Hill, A. V. S., & Flanagan, K. L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002027 · Cited by 134
“NK cells and cd T cells may have direct effector functions or may modulate other immune responses [1,2], whilst naturally-occurring CD4CD25 FOXP3 regulatory T cells may be suppress immunity [3,4,5].”
BackgroundEwing, M. M., Karper, J. C., Abdul, S., de Jong, R. C. M., Peters, H. A. B., de Vries, M. R., Redeker, A., Kuiper, J., Toes, R. E. M., Arens, R., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.12.085 · Cited by 138
CD8+ Tregs in lupus, autoimmunity, and beyond
Dinesh, R. K., Skaggs, B. J., Cava, A. L., Hahn, B. H., & Singh, R. P. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.03.006 · Cited by 143
“Renewed interest in regulatory T cells followed the discovery of CD4+CD25+ Tregs some decades later, as these cells were found to suppress effector T cells and inflammatory cytokines and thus play an important role in immune homeostasis and tolerance [7-11].”
BackgroundHahn, B. H., Singh, R. P., Cava, A. L., & Ebling, F. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7728 · Cited by 133
Efficient Treg depletion induces T‐cell infiltration and rejection of large tumors
Li, X., Kostareli, E., Suffner, J., Garbi, N., & Hämmerling, G. J. (2010) · European Journal of Immunology · doi:10.1002/eji.201041093 · Cited by 126
Immune privilege in sites of chronic infection: Leishmania and regulatory T cells
Peters, N., & Sacks, D. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00432.x · Cited by 132
Immune regulation and vascular inflammation in genetic hypertension
Viel, É. C., Lemarié, C. A., Benkirane, K., Paradis, P., & Schiffrin, E. L. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00707.2009 · Cited by 144
Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?
Kumar, V. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9349-9 · Cited by 150
Th17 Pathway-Mediated Immunopathogenesis of Schizophrenia: Mechanisms and Implications
Debnath, M., & Berk, M. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu049 · Cited by 129
CD28 Controls Differentiation of Regulatory T Cells from Naive CD4 T Cells
Guo, F., Iclozan, C., Suh, W.-K., Anasetti, C., & Yu, X.-Z. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2285 · Cited by 129
“Discussion Regulation by Tregs is an important mechanism of peripheral tolerance responsible for controlling autoreactive T cells (14).”
BackgroundDelineating the autoimmune mechanisms in Graves’ disease
MORSHED, S. A., Latif, R., & Davies, T. F. (2012) · Immunologic Research · doi:10.1007/s12026-012-8312-8 · Cited by 131
Interleukin-2-Dependent Mechanisms of Tolerance and Immunity In Vivo
Antony, P. A., Paulos, C. M., Ahmadzadeh, M., Akpınarlı, A., Palmer, D. C., Sato, N., Kaiser, A., Hinrichs, C. S., Klebanoff, C. A., Tagaya, Y., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5255 · Cited by 159
Transcriptional and posttranslational regulation of Th17/Treg balance in health and disease
Zhang, W., Liu, X., Zhu, Y., Liu, X., Gu, Y., Dai, X., & Li, B. (2021) · European Journal of Immunology · doi:10.1002/eji.202048794 · Cited by 137
Stross, L., Günther, J., Gasteiger, G., Asen, T., Graf, S., Aichler, M., Esposito, I., Busch, D. H., Knolle, P., Sparwasser, T., et al. (2012) · Hepatology · doi:10.1002/hep.25765 · Cited by 126
“CD4þFoxp3þ Tregs were originally shown to be a specialized T cell subpopulation suppressing autoreactive T cell responses and maintaining immunological tolerance.(4) This T cell subset was first characterized by constitutive surface expression of the interleukin-2 receptor alpha (CD25),(5,6) but CD25 is also expressed…”
Wang, J., Takeuchi, H., Sonobe, Y., Jin, S., Mizuno, T., Miyakawa, S., Fujiwara, M., Nakamura, Y., Kato, T., Muramatsu, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709592105 · Cited by 129
Kuwahara, T., Hazama, S., Suzuki, N., Yoshida, S., Tomochika, S., Nakagami, Y., Matsui, H., Shindo, Y., Kanekiyo, S., Tokumitsu, Y., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0559-6 · Cited by 150
Interplay between pathogenic Th17 and regulatory T cells
Oukka, M. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.078527 · Cited by 128
Hoek, A., Rutten, V. P. M. G., Kool, J., Arkesteijn, G. J. A., Bouwstra, R., Rhijn, I. V., & Koets, A. P. (2008) · Veterinary Research · doi:10.1051/vetres:2008044 · Cited by 127
Inherited and SomaticCD3ζ Mutations in a Patient with T-Cell Deficiency
Rieux‐Laucat, F., Hivroz, C., Lim, A., Mateo, V., Pellier, I., Selz, F., Fischer, A., & Deist, F. L. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053750 · Cited by 127
FOXP3 and Its Role in the Immune System
Kim, C. H. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1599-3_2 · Cited by 136
Elpek, K. G., Lacelle, C., Singh, N. P., Yolcu, E. S., & Shirwan, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6840 · Cited by 124
“CD4 CD25 FoxP3 Treg cells have recently been the focus of intense studies due to their critical roles in tolerance to self Ags and regulation of immune responses to infections and transplantation Ags (7).”
BackgroundInfluentialTarbell, K. V., Yamazaki, S., & Steinman, R. M. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.01.009 · Cited by 126
Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells
Wang, F., Wan, L., Zhang, C.-C., Zheng, X., Li, J., & Chen, Z. K. (2008) · Immunobiology · doi:10.1016/j.imbio.2008.10.007 · Cited by 130
Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators
Sørensen, R. B., Hadrup, S. R., Svane, I. M., Hjortsø, M. C., Straten, P. T., & Andersen, M. H. (2010) · Blood · doi:10.1182/blood-2010-06-288498 · Cited by 131
Verdu, E. F., Huang, X., Natividad, J., Lu, J., Blennerhassett, P. A., David, C. S., McKay, D. M., & Murray, J. A. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00225.2007 · Cited by 125
“FOX-P3 ϩ cell staining was counted in the lamina propria in five villi randomly chosen using two different sections per mouse.”
BackgroundInfluentialPrognostic significance of regulatory T cells in tumor
Wilke, C. M., Wu, K., Zhao, E., Wang, G., & Zou, W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25464 · Cited by 120
van Mierlo, G. J. D., Scherer, H. U., Hameetman, M., Morgan, M. E., Flierman, R., Huizinga, T. W. J., & Toes, R. E. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.2747 · Cited by 124
Metadata
- Authors
- Sakaguchi, S.
- Affiliations
- Kyoto University (JP)
- Corresponding author
- Sakaguchi, Shimon
- ORCID
- Sakaguchi, Shimon
- Venue
- Nature Immunology
- Published
- 2005-03-22
- Volume
- 6
- Issue
- 4
- Pages
- 345-352
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2004708987
- Cited by
- 2,669
- References
- 109
- Citations by year
- 2026: 12 · 2025: 33 · 2024: 39 · 2023: 54 · 2022: 59 · 2021: 68 · 2020: 68 · 2019: 84 · 2018: 83 · 2017: 92 · 2016: 98 · 2015: 113 · 2014: 127 · 2013: 148 · 2012: 169
- FWCI
- 22.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- Foxp3, regulatory T cells, CD4+CD25+ T cells, immune tolerance, self-tolerance, autoimmune disease, antitumor immunity, transplantation tolerance, antigen-specific T cell expansion, immunomodulation
- MeSH terms
- Animals, Antigens, Differentiation, Autoimmune Diseases, DNA-Binding Proteins, Humans, Lymphocyte Activation, Neoplasms, T-Lymphocytes, Thymus Gland, Transplantation Immunology, Receptors, Interleukin-2, Antigens, CD, CD4 Antigens, Self Tolerance, Forkhead Transcription Factors, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.